Categories: LATEST NEWS

Award Success for CPI Partner Company Stream Bio Limited

A CPI partner company has received an industry accolade.

Stream Bio Limited, which develops and manufactures a range of revolutionary bioimaging molecular probes, has been presented with an Institute of Physics Business Start-Up Award.

The honour reflects Stream Bio’s novel conjugated polymer nanoparticles (CPN™) technology and celebrates its entrepreneurship and excellence in innovation.

The annual Business Start-Up Award is the only recognition in the UK and Ireland that commemorates young companies on their innovative application of physics and their excellent business growth potential.

Stream Bio was recognised for its successful implementation of physics into CPN™.

With CPNs™ having a fluorescent polymer core and magnetic capability, being non-toxic and extremely bright and stable compared to current fluorescent markers, the technology could help revolutionise rapid diagnostics tests, such as those for HIV and syphilis.

In the not too distant future, it is also expected to positively impact in vivo imaging and therapeutics.

Established in 2015, Stream Bio has worked closely with CPI to bring its technology to commercialisation, with its CPN’s™ being initially developed for use in molecular R&D applications, such as flow cytometry, EliSA, western blotting and lateral flow assays.

CPI’s formulation facilities have played an integral role in the scale-up and development, with the organisation’s biologics expertise assisting with the creation of proof of concept data.

Andy Chaloner, Stream Bio Chief Executive, said: “We are honoured to have won this award from the distinguished Institute of Physics.

“Our team has worked hard to bring this technology to the market and it is very exciting to have it recognised in this way.

“The exposure this award brings will drive the technology further and we can’t wait to see what the future will hold.”

Earlier this year, Mr Chaloner was part of a Government trade mission to China that aimed to create stronger business ties between the UK and the Asian country.

During the trip, Mr Chaloner, on behalf of Stream Bio, helped demonstrate the huge developments in the future of medicine happening at CPI and in the UK at present, across sectors including pharmaceuticals, medical devices and biologics.

Liat

Comments are closed.

Recent Posts

BeyondTrust Acquires Entitle, Strengthening Privileged Identity Security Platform with Paradigm Shifting Just-in-Time Access and Identity Governance

Entitle is a pioneering privilege management solution that discovers, manages, and automates just-in-time (JIT) access and modern identity governance and…

2 weeks ago

Samtec Introduces SIBORG Tool to Speed Component Launch Designs

Available freely to Samtec customers under NDA, SIBORG (Signal Integrity Breakout Region Guru) works with Ansys HFSS 3D Layout to…

2 weeks ago

Accelerating Mass Business AI Adoption: NeuReality Launches Developer Portal for NR1 Inference Platform, Expanding Affordable AI Access

Entire NR1 system purpose-built for a more affordable AI infrastructure allowing for faster deployment; furthering AI’s reach into more parts…

3 weeks ago

Dot Compliance Raises a $17.5 Million Up-Round in Series B Extension Funding to Advance New Category of AI-driven Compliance

Following rapid growth in its customer base to over 400, funding will fuel further AI development and create a hybrid…

3 weeks ago

Tektronix and recently acquired EA Elektro-Automatik now offer expanded power portfolio for engineers who are electrifying our world

The addition of EA’s high-efficiency regenerative power supplies greatly expands Tektronix’s trusted offering Tektronix, Inc, a leading provider in test…

3 weeks ago

Melexis unveils fully integrated inductive switch

Melexis reveals its groundbreaking Induxis® switch, the MLX92442. Contactless, magnet-free, and strayfield immune, this monolithic solution directly detects conductive targets.…

3 weeks ago